Skip to main content
Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
8.29
-0.07 (-0.84%)
Dec 3, 2024, 11:38 AM EST - Market open

Addex Therapeutics Revenue

Addex Therapeutics had revenue of 58.35K CHF in the quarter ending September 30, 2024, a decrease of -82.28%. This brings the company's revenue in the last twelve months to 592.36K, down -71.27% year-over-year. In the year 2023, Addex Therapeutics had annual revenue of 1.65M with 13.99% growth.

Revenue (ttm)
592.36K CHF
Revenue Growth
-71.27%
P/S Ratio
n/a
Revenue / Employee
25,755 CHF
Employees
23
Market Cap
6.91M USD

Revenue Chart

* This company reports financials in CHF.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.65M202.11K13.99%
Dec 31, 20221.44M-1.71M-54.18%
Dec 31, 20213.15M-725.84K-18.71%
Dec 31, 20203.88M1.05M36.89%
Dec 31, 20192.83M-3.87M-57.72%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Biofrontera 35.36M
Evoke Pharma 8.62M
Biomerica 5.51M
Tenon Medical 3.32M
Intelligent Bio Solutions 3.19M
Kindly MD 2.88M
Xenetic Biosciences 2.52M
Biora Therapeutics 892.00K
Revenue Rankings

ADXN News

More News